Casciato Sara, Di Bonaventura Carlo, Giallonardo Anna Teresa, Fattouch Jinane, Quarato Pier Paolo, Mascia Addolorata, D'Aniello Alfredo, Romigi Andrea, Esposito Vincenzo, Di Gennaro Giancarlo
Epilepsy Unit, Department of Neurology and Psychiatry, "Sapienza" University, Rome, Italy.
Neurosurg Rev. 2015 Jul;38(3):463-70; discussion 470-1. doi: 10.1007/s10143-015-0623-5. Epub 2015 Apr 16.
Rasmussen's encephalitis (RE) is a rare immune-mediated condition characterized by drug-resistant focal epilepsy, progressive neurological, and cognitive deficits associated to unilateral hemispheric atrophy. The onset is typically reported in childhood, although adult cases (A-RE) have been described. While surgical strategies in childhood RE are well defined, little is known about usefulness of epilepsy surgery in A-RE patients. We describe clinical features, surgical approach, and outcome of five A-RE patients who underwent epilepsy surgery, and we review the literature with regard to surgical A-RE cases. We retrospectively studied five A-RE patients aged 21-38 years (mean age 22.8 years) who were followed after surgery for a period ranging from to 1 to 6 years. Demographic, electroclinical, and neuroimaging data were systematically reviewed. Four out of five subjects underwent invasive EEG monitoring to define epileptogenic zone. Epilepsy outcome was defined according to Engel's classification. Surgery consisted of frontal corticectomy in three patients, temporal lobectomy in one, combined temporal lobectomy plus insular, and frontobasal corticectomy in the remaining case. No permanent neurological deficits were observed after surgery. At the last follow-up observation, one patient was seizure-free, two subjects experienced rare disabling seizures, another had moderate seizure reduction, and one had no clinical improvement. Our experience, although limited to few cases, suggests that resective surgery in A-RE may play a role in the context of multidisciplinary therapeutical approach of this severe condition. Since the lack of specific data about surgical options, this topic seems to deserve further investigations and more targeted studies.
拉斯穆森脑炎(RE)是一种罕见的免疫介导性疾病,其特征为耐药性局灶性癫痫、进行性神经功能和认知缺陷,并伴有单侧半球萎缩。虽然成人病例(A-RE)已有报道,但该病通常在儿童期发病。尽管儿童RE的手术策略已明确,但对于A-RE患者癫痫手术的有效性知之甚少。我们描述了5例接受癫痫手术的A-RE患者的临床特征、手术方法和预后,并回顾了有关A-RE手术病例的文献。我们回顾性研究了5例年龄在21 - 38岁(平均年龄22.8岁)的A-RE患者,术后随访1至6年。系统回顾了人口统计学、电临床和神经影像学数据。5名患者中有4名接受了侵入性脑电图监测以确定癫痫灶。癫痫预后根据恩格尔分类法确定。3例患者行额叶皮质切除术,1例行颞叶切除术,1例联合颞叶切除术加岛叶切除术,最后1例行额底部皮质切除术。术后未观察到永久性神经功能缺损。在最后一次随访观察时,1例患者无癫痫发作,2例患者偶有致残性发作,另1例患者癫痫发作中度减少,1例患者无临床改善。我们的经验虽然仅限于少数病例,但表明A-RE的切除性手术在这种严重疾病的多学科治疗方法中可能发挥作用。由于缺乏关于手术选择的具体数据,这个话题似乎值得进一步研究和更有针对性的研究。